RONALD SHORE, M.D.
Dermatology at Randolph Rd, Rockville, MD
License number
Maryland D20596
Category
Osteopathic Medicine
Type
Dermatology
Address
Address
4701 Randolph Rd SUITE 201, Rockville, MD 20852
Phone
(410) 872-9188
Personal information
See more information about RONALD SHORE at radaris.comName
Address
Phone
11420 Rockville Pike, Rockville, MD 20852
9721 Sorrel Ave, Potomac, MD 20854
9800 Falls Rd, Potomac, MD 20854
4701 Randolph Rd, Rockville, MD 20852
Professional information
See more information about RONALD SHORE at trustoria.com
Dr. Ronald Shore, Rockville MD - MD (Doctor of Medicine)
Dr. Ronald Shore, Rockville MD - MD (Doctor of Medicine)
Specialties:
Dermatology
Address:
Ronald N Shore MD
4701 Randolph Rd SUITE 207, Rockville 20852
(301) 468-2100 (Phone)
4701 Randolph Rd SUITE 207, Rockville 20852
(301) 468-2100 (Phone)
Certifications:
Dermatology, 1975
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Ronald N Shore MD
4701 Randolph Rd SUITE 207, Rockville 20852
Johns Hopkins Bayview Medical Center
4940 Eastern Ave, Baltimore 21224
4701 Randolph Rd SUITE 207, Rockville 20852
Johns Hopkins Bayview Medical Center
4940 Eastern Ave, Baltimore 21224
Education:
Medical School
University of Saskatchewan / College of Medicine
The Johns Hopkins Hospital
Hospital Of The University Of Pennsylvania
University of Saskatchewan / College of Medicine
The Johns Hopkins Hospital
Hospital Of The University Of Pennsylvania
Methods And Algorithms For Aiding In The Detection Of Cancer
Methods And Algorithms For Aiding In The Detection Of Cancer
US Patent:
2013019, Aug 1, 2013
Filed:
Dec 18, 2012
Appl. No.:
13/718457
Inventors:
Ronald Shore - Rockville MD, US
Assignee:
20/20 GENESYSTEMS, INC. - Rockville MD
International Classification:
G01N 33/68
US Classification:
506 9, 506 18, 702 19
Abstract:
A method of data interpretation from a multiplex cancer assay is described. The aggregate normalized score from the assay is transformed to a quantitative risk score quantifying a human subject's increased risk for the presence of cancer as compared to the known prevalence of the cancer in the population before testing the subject.